000 01474 a2200433 4500
005 20250513110101.0
264 0 _c19970319
008 199703s 0 0 eng d
022 _a0306-5251
024 7 _a10.1046/j.1365-2125.1996.00500.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBasci, N E
245 0 0 _aProguanil metabolism in relation to S-mephenytoin oxidation in a Turkish population.
_h[electronic resource]
260 _bBritish journal of clinical pharmacology
_cDec 1996
300 _a771-3 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAnticonvulsants
_xpharmacokinetics
650 0 4 _aAntimalarials
_xpharmacokinetics
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMephenytoin
_xpharmacokinetics
650 0 4 _aOxidation-Reduction
650 0 4 _aPhenotype
650 0 4 _aPolymorphism, Genetic
650 0 4 _aPopulation
650 0 4 _aProguanil
_xpharmacokinetics
650 0 4 _aSpectrophotometry, Ultraviolet
650 0 4 _aTurkey
700 1 _aBozkurt, A
700 1 _aKortunay, S
700 1 _aIsimer, A
700 1 _aSayal, A
700 1 _aKayaalp, S O
773 0 _tBritish journal of clinical pharmacology
_gvol. 42
_gno. 6
_gp. 771-3
856 4 0 _uhttps://doi.org/10.1046/j.1365-2125.1996.00500.x
_zAvailable from publisher's website
999 _c8963154
_d8963154